Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 496
Aptamer sequence: TTGGGGTCTGCTCGGGATTGCGGAGAACGTGAATCT
Target unique ID: Q81258
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_491 r10/47 Protein POLG_HCVNZ 23.5 nM HEPES-buffered saline containing 1 mM CaCl2, 2.7 mM MgCl2, and 0.005% surfactant P-20 (HBS-CKM) 16940097
Structure information of aptamer
Aptamer Sequence: TTGGGGTCTGCTCGGGATTGCGGAGAACGTGAATCT
The optimal secondary structure in dot-bracket notation: .((((.....))))((((((((.....))).)))))
The centroid secondary structure in dot-bracket notation: ..(((.....))).((((.(((.....)))..))))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_491 Description r10/47
Aptamer chemistry DNA Length 36 nt
GC content 55.6% Molecular weight 11,203.18 Da
Molarity of 1 μg/μl solution 89.26 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence TTGGGGTCTGCTCGGGATTGCGGAGAACGTGAATCT
Applications Inhibition of HCV
Target information
Type Detail Type Detail
Uniprot ID Q81258 Protein name Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Gene name(s) N/A Organism Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Status reviewed in uniprot database Length 3021
Mass 329,578 Activity regulation Inhibited by the antiviral drug hexamethylene amiloride (By similarity)
Involvement in disease N/A Catalytic activity Reaction=Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1
PDB ID(s)
6P6S;
Function Packages viral RNA to form a viral nucleocapsid, and promotes virion budding.
Activity data
Interaction ID 496
Target type Protein
Target unique ID Q81258
Activity 23.5 nM
Binding Conditions/Buffer

HEPES-buffered saline containing 1 mM CaCl2, 2.7 mM MgCl2, and 0.005% surfactant P-20 (HBS-CKM)

Assay

The percentage of aptamer bound is plotted against the concentration of polymerase. Estimated values for KD are also shown. Results are expressed as the means of three replicates, and error bars represent the standard errors of the means

PubMed ID 16940097
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_364 DNA TATGGTATGCTGTGTGGTATGGGGTGGCGTGCTCT 58.33%
Apta_1240 DNA GGAGTAGTGGGGATTGTGGTGTATGTTGTC 58.33%
Apta_861 DNA CAGGTTGGTCTGGTTGGGTTTGGCTCCTGTGTACGCAACCTG 57.14%
Apta_671 DNA GCATCTGATCGGGTGTGGGTGGCGTAAAGG 55.56%
Apta_1195 DNA GGGGTTGGGGGGAGGCGGGGAATGGGGG 55.56%
Apta_35 DNA TGGGTGGCCTCCCGTTTATTCGAGATTTGGTTGAATTTGT 55.00%
Apta_266 DNA TGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCT 55.00%
Apta_857 DNA GCTATGGGTGGTCTGGTTGGGATTGGCCCCGGGAGCTGGC 55.00%
Apta_1261 DNA GGGCGGACGCTAGGTGGTGATGCTGTGCTACACGTGTTGT 55.00%
Apta_943 DNA GAAGGTGGAGCGGTTAGGATACTAGCGAATGAAGACACGTTAGCTGATCT 54.00%
Apta_666 DNA TCGACCTCGCGCGAGGAGGGTGGAGGGTCGTAGAGCGCGTA 53.66%
Apta_617 DNA CAATGGGGTCGGGCGGGCCGGGTGTCATGGTGGACGGAGATGGGACGTAGAGGGCGGT 53.45%
Apta_255 DNA TAGCGATACTGCGTGGGTTGGGGCGGGTAGGGCCAGCAGTCTCGT 53.33%
Apta_1156 DNA TTCTGGTGTGGTAACTCATGTATCGGTCGTGGGGGTCGTGGCATT 53.33%
Apta_930 DNA TTGCACTATGTTTTAGCTAGGGTTCCCTCCGGAGATAGTAAGTGCAA 53.19%
Apta_143 DNA GGTGCGGTTCGTGCGGTTGTAGTACTCGTGGCCGATAGAGGTAGTTTCG 53.06%
Apta_1162 DNA AGAGGCTACAGCGATAAGTCGACATTGCTGACCGTACCTAGTAATACGT 53.06%
Apta_16 DNA AGGGGGGGGGGACGGGACGGGTATA 52.78%
Apta_18 DNA TGGGGGGTTGGACGGGCGGGGCTGC 52.78%
Apta_22 DNA TGTGGGGGTGGACTGGGTGGGTACC 52.78%